NanoViricides
NNVC
30 hedge funds and large institutions have $1.61M invested in NanoViricides in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 4 closing their positions.
3,900% more call options, than puts
Call options by funds: $40K | Put options by funds: $1K
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
14% more capital invested
Capital invested by funds: $1.42M → $1.61M (+$193K)
11% more funds holding
Funds holding: 27 → 30 (+3)
0.29% less ownership
Funds ownership: 10.58% → 10.29% (-0.29%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$43.2K |
| 2 |
MAWA
Moss Adams Wealth Advisors
Seattle,
Washington
|
+$17K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$14.4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$825 |
| 5 |
FAM
Flaharty Asset Management
Clearwater,
Florida
|
+$283 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$49.5K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$27.8K |
| 3 |
Two Sigma Investments
New York
|
-$22.8K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$4.19K |
| 5 |
Renaissance Technologies
New York
|
-$3.54K |
NNVC Hedge Fund Activity: Q3 2023 in Review
30 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q3 2023, worth a combined $1.61M — up 14% from $1.42M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new NNVC positions and 4 closed out — a net gain of 3 holders — while 0 added to existing stakes and 5 trimmed.
The largest buyer was Royal Bank of Canada, opening a new position worth an estimated $43.2K. The largest seller was Bridgeway Capital Management, cutting an estimated $49.5K.
- 30 institutional investors held NanoViricides (NNVC) as of Q3 2023, up from 27 in Q2 2023.
- Funds reported $1.61M of NanoViricides stock for Q3 2023, up 14% quarter-over-quarter.
- 7 funds opened new NanoViricides positions in Q3 2023 and 4 closed out, a net change of +3 holders.
- The largest NanoViricides buyer in Q3 2023 was Royal Bank of Canada, an estimated $43.2K added.
- The largest NanoViricides seller in Q3 2023 was Bridgeway Capital Management, an estimated $49.5K sold.
Based on aggregated 13F filings for Q3 2023.